S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ELVN Enliven Therapeutics Inc

22.50

0.11 (0.49%)

01 Jan 2025 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Enliven Therapeutics Charts.

Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Enliven Therapeutics Charts.

Enliven Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 1 January 2025 (12 hours ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 28 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 16 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 16 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Thursday 14 November 2024 (2 months ago) • PR Newswire (US)

More Enliven Therapeutics Inc News Articles

ETFS Gold Bullion Securi...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions